Viral Antigens Current Events | Viral Antigens News | 3
|
| Page
3 of
25 |
490 Results |
|
|
|
Sort By:
Page Views | Date |
Six months after start of treatment could be optimum time for making prognosis in patients with HIV/AIDS (p 679)
Issue 30 August 2003 Embargoed 0001 h (London time) 29 August 2003. An international study in this week's issue of THE LANCET suggests that prognosis for patients with HIV/AIDS might be more reliably determined six months after initiation of highly active antiretroviral therapy (HAART), rather than before the start of treatment. HAART became... view more... (2003-08-27)
Advances in HBV DNA assays are key to determine best long-term treatment strategies for Hepatitis B
For the 350 million people chronically infected with HBV, the two therapeutic approaches currently available are immunomodulatory agents and antiviral chemotherapy. The first therapeutic agent was interferon-alpha (IFN-alpha), whose dual mode of action includes both antiviral and immunomodulatory effects. Unfortunately, extended IFN-alpha... view more... (2005-01-10)
Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
A new study has found an unexpected number of viruses and viral subtypes in patients with respiratory tract infections (RTIs). The technique used in the study may help identify new viruses associated with human diseases. view more (2007-09-07)
MicroRNAs may be key to HIV's ability to hide, evade drugs, Jefferson scientists find
Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. view more (2007-10-01)
Protein Sequences: Not So Predictable After All
Scientists have believed for decades that the sequencing of the human genome would automatically yield the sequences of proteins, the functional products of genes, and thus lead to the unraveling of the mechanisms behind human cell biology and disease. However, a paper published in Science today by the Ludwig Institute for Cancer Research (LICR)... view more... (2004-03-01)
Rare immune cell is key to transplant's cancer-killing effect
Researchers at the University of Michigan's Comprehensive Cancer Center have discovered the secret weapon behind the most powerful form of cancer immunotherapy known to medicine. view more (2005-10-17)
Jefferson researchers' discovery may change thinking on how viruses invade the brain
A molecule thought crucial to ferrying the deadly rabies virus into the brain, where it eventually kills, apparently isn't. view more (2007-04-20)
Epstein-Barr Virus Might Kick-Start Multiple Sclerosis
Researchers have found that patients with multiple sclerosis (MS) carry a population of immune cells that overreact to Epstein-Barr virus. view more (2006-05-02)
Scripps research team develops new technique to tap full potential of antibody libraries
In hopes of more fully tapping the libraries' potential, a group of Scripps Research Institute scientists, led by Scripps Research President Richard A. Lerner, M.D., has for the first time developed a new screening technique that enables antibody screening against equally massive libraries of targets. view more (2009-01-16)
STDs disrupt genetic bottleneck that usually constrains HIV infection
Scientists have shown that HIV faces a genetic "bottleneck" when the virus is transmitted heterosexually from one person to another, by way of the genital mucosa. view more (2009-01-23)
A new view of asthma's cause
A newly recognized type of immune cell may play an important role in causing asthma, perhaps explaining why current therapies sometimes fail, report researchers from Children's Hospital Boston in the March 16th New England Journal of Medicine. view more (2006-03-16)
New method for HIV testing holds promise for developing world
A new technique that detects the HIV virus early and monitors its development without requiring refrigeration may make AIDS testing more accessible in sub-Saharan Africa. view more (2009-07-22)
SLU Researchers Uncover Direct Evidence on How HIV Invades Healthy Cells
Using sophisticated detection methods, researchers at the Saint Louis University Institute for Molecular Virology (IMV) have demonstrated the molecular mechanism by which the HIV virus infects, or integrates, healthy cells. The discovery could lead to new drug treatments for HIV. view more (2005-12-22)
Baiting bacteria with polymers
Anyone who has experienced food poisoning while on vacation in warm climates is sure to recognize the importance of safeguarding hygiene - and of microbial food testing. Since many types of bacteria, such as salmonella, multiply at an exceptionally fast rate in warm weather on meat or in milk products, relatively lengthy laboratory investigations... view more... (2002-09-20)
First evidence for DNA-based vaccination against chronic hepatitis C
The first-proof-of-concept for a DNA-based therapeutic vaccination against chronic hepatitis C was announced today at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark. view more (2009-04-23)
Herpes virus link to complications in pregnancy
Researchers at Adelaide's Women's & Children's Hospital and the University of Adelaide, Australia, have made a world-first discovery that links viral infection with high blood pressure during pregnancy and pre-term birth. view more (2008-02-19)
Yale study shows why cigarette smoke makes flu, other viral infections worse
A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette smoke interact to increase lung... view more... (2008-07-25)
Early exposure to common viral infection does not protect against allergy
Common viral infections in early childhood do not protect against allergy, concludes research in Thorax. If anything, the evidence points to an increased risk. view more (2002-04-25)
Oxford Biomedica Plc And Arius Research Inc. Sign Collaborative Programme In Tumour Immunotherapy
Oxford, United Kingdom and Toronto, Canada - 25 July 2002. Oxford BioMedica plc (LSE:OXB) ("BioMedica") and ARIUS Research Inc. ("ARIUS) of Canada announced today a research and development collaboration to search for targets and develop novel products to treat cancer. Under the collaboration ARIUS will supply BioMedica with a... view more... (2002-07-25)
Moving gene therapy forward with mobile DNA
Gene therapy is the introduction of genetic material into a patient's cells resulting in a cure or a therapeutic effect. In recent years, it has been shown that gene therapy is a promising technology to treat or even cure several fatal diseases for which there is no attractive alternative therapy. view more (2009-05-04)
|
|
| Page
3 of
25 |
490 Results |
|
|
|
Sort By:
Page Views | Date |
|
